SAN FRANCISCO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action, offering a new opportunity for investors to represent the class. The action follows the court's decision on August 4, 2025, to disqualify the previously appointed lead plaintiff. The new deadline to apply is September 24, 2025.

Hagens Berman urges Spectrum investors who suffered substantial losses to submit your losses now .

Class Period: Mar. 17, 2022 – Sept. 22, 2022

Lead Plaintiff Deadline: Sept. 24, 2025

Visit: www.hbsslaw.com/investor-fraud/sppi

Contact the Firm Now: SPPI@hbsslaw.com

844-916-0895

The federal class action, Christiansen v. Spectrum Pharmaceuticals, Inc., et al. , has been ongoing i

See Full Page